Prophylactic Peripheral Blood Stem Cell Collection in Patients with Extensive Bone-Marrow Infiltration of Neuroendocrine Tumours Prior to Peptide Receptor Radionuclide Therapy with ¹⁷⁷Lu-DOTATATE

• Egile Nagusiak: Amir Sabet (Egilea), Nicolai Mader (Egilea), Jörg Thomas Bittenbring (Egilea), Fadi Khreish (Egilea), Frank Grünwald (Egilea), Hans Jürgen Biersack (Egilea), Samer Ezziddin (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2021-10-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Peptide receptor radionuclide therapy (PRRT) of metastatic neuroendocrine tumors (NET) can be successfully repeated but may eventually be dose-limited. Since ¹⁷⁷Lu-DOTATATE dose limitation may come from hematological rather than renal function, hematological peripheral blood s...